نتایج جستجو برای: abvd
تعداد نتایج: 396 فیلتر نتایج به سال:
The endobronchial localization of Hodgkin's disease is a rare entity which is often confused with endobronchial tuberculosis in our setting. We report the case of a 16 years old female who presented with 6 months history of dry cough, hemoptysis, dyspnea, dysphagia and dysphonia. The chest radiography showed a mediastinal and pulmonary opacity. The chest CT scan found enlarged mediastinal lymph...
Peripheral progesterone titers characterizing the reproductive cycle of bitch are fairly well-documented in literature. Progesterone obtained via fluorescence-immunoassay technique at different points to appearance-of-bloody-vulva-discharge (ABVD) apparently healthy, exotic, multi-breed bitches (n = 76) that were subsequently inseminated summarized using descriptive statistics. The recommended/...
Nearly 7500 new cases of Hodgkin’s disease are diagnosed in the United States annually. This disease is one of the first malignancies and can be cured in about 75% of cases. The main objective of this study was to create a major sight on Hodgkin’s disease, the result of its treatment and its 5 and 10-year survival by considering this point that early diagnosis, on time management of the patient...
BACKGROUND The bleomycin-etoposide-doxorubicin-cyclophosphamide-vincristine-procarbazine-prednisone (BEACOPP) regimen was developed to investigate the potential of moderate dose escalation of conventional polychemotherapy to improve the unsatisfactory treatment results in advanced-stage Hodgkin's lymphoma (HL). Following pilot studies, the randomised trial HD 9 demonstrated that BEACOPP (baseli...
To determine the clinical significance of BCL-2 expression in Hodgkin-Reed-Sternberg (HRS) cells of classical Hodgkin disease (cHD), we correlated its expression with presenting clinical and laboratory features and failure-free survival (FFS). Eligible patients were untreated and negative for HIV-1; they had biopsyproven cHD. BCL-2 expression was determined immunohistochemically in available pr...
Background: Though the outcome of patients with stage I/II HL is excellent standard combined chemo- and radiotherapy, H10 trial assessed possibility improving tumor control by treatment intensification in early (i.e., after two cycles ABVD) PET-positive reducing related toxicity omission involved-node radiotherapy (INRT) PET-negative patients. Here, we present results 10y long term follow-up an...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید